![]() |
市場調査レポート
商品コード
1518346
デジタル病理学市場:製品別、用途別、エンドユーザー別-2030年までの世界予測Digital Pathology Market by Offering (Hardware, Software, Service), Application (Diagnostic, Drug Discovery, Training), End User (Hospital, Academic Institute) - Global Forecast to 2030 |
||||||
カスタマイズ可能
|
デジタル病理学市場:製品別、用途別、エンドユーザー別-2030年までの世界予測 |
出版日: 2024年06月01日
発行: Meticulous Research
ページ情報: 英文 185 Pages
納期: 5~7営業日
|
デジタル病理学市場は、2023~2030年のCAGRが8.7%で、2030年には18億6,000万米ドルに達すると予測されています。
本レポートでは、広範な2次調査と1次調査、市場シナリオの詳細な分析を経て、主要な業界促進要因、抑制要因、市場促進要因・課題の分析を提供しています。
この市場の成長は、慢性疾患の有病率の上昇、ラボの効率性を高めるためのデジタル病理学ソリューションの採用の増加、コンパニオン診断や医薬品開発におけるデジタル病理学診断の応用の広がりによってもたらされます。しかし、デジタル病理学試験サービスに対する償還がないことが、この市場の成長を抑制しています。
さらに、個別化医療に対する需要の高まり、民間病理クリニック向けの手頃な価格のスキャナーの発売、新興経済諸国は、デジタル病理学ソリューションプロバイダーにとって大きなビジネス機会を生み出しています。しかし、デジタル病理学における法的規制のハードルや訓練を受けた病理医の不足は、この市場における大きな課題です。
Digital Pathology Market Size, Share, Forecast, & Trends Analysis by Offering (Hardware [Scanner, Tissue Microarray], Software [Information Management, Image Analysis], Service), Application (Diagnostic, Drug Discovery), End User-Global Forecast to 2030
The digital pathology market is projected to reach $1.86 billion by 2030 at a CAGR of 8.7% from 2023 to 2030.
Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges.
The growth of this market is driven by the rising prevalence of chronic diseases, the increasing adoption of digital pathology solutions to enhance lab efficiency, and the widening applications of digital pathology in companion diagnostics and drug development. However, the lack of reimbursements for digital pathology services restrains the growth of this market.
Furthermore, the rising demand for personalized medicine, the launch of affordable scanners for private pathology practices, and developing economies are generating significant opportunities for digital pathology solutions providers. However, the legal and regulatory hurdles in digital pathology and the shortage of trained pathologists are major challenges in this market.
The report offers a competitive landscape based on an extensive assessment of the product portfolios, geographic presence, and key strategic developments of leading market players during the last four years (2020-2023). The key players operating in the digital pathology market are 3DHISTECH Ltd. (Hungary), Leica Microsystems (a subsidiary of Danaher Corporation) (Germany), Hamamatsu Photonics K.K. (Japan), Nikon Corporation (Japan), Visiopharm A/S (Denmark), Koninklijke Philips N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Glencoe Software, Inc. (U.S.), XIFIN, Inc. (U.S.), and PerkinElmer Inc. (U.S.).
Based on offering, in 2023, the hardware segment is expected to account for the largest share of the digital pathology market. The large market share of this segment is attributed to the increased demand for precise & accurate diagnosis and an increase in patients requiring in vitro tests.
Based on application, in 2023, the disease diagnosis segment is expected to account for the largest share of the digital pathology market. The large market share of this segment is attributed to the high burden of chronic diseases, the high adoption of teleconsulting, and rising awareness about the importance of early disease diagnosis.
Based on end user, in 2023, the hospitals & clinics segment is expected to account for the largest share of the digital pathology market. The large market share of this segment is attributed to the increased availability and affordability of advanced technological pathology solutions at hospitals, the higher preference for hospitals/clinics as a primary center for care, and the high volume of patient inflow in hospitals & clinics.
An in-depth analysis of the geographical scenario in the digital pathology market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the digital pathology market. Furthermore, in 2023, the U.S. is expected to hold the major market share in North America. Market growth in the U.S. is driven by the digitization of pathology services, high investments in R&D, the high adoption of advanced technologies, and the increased demand for reliable and faster diagnostics.
Digital Pathology Market Assessment-by Offering
Note 1: Other hardware includes clinical microscopes and accessories.
Note 2: Other software includes digital storage systems, tissue microarray software, and telepathology platforms.
Digital Pathology Market Assessment-by Application
Digital Pathology Market Assessment-by End User
Digital Pathology Market Assessment-by Geography